Article
The Prognostic Utilities of DNA Mismatch Repair Status and KRAS and BRAF Mutation in Korean Colorectal Cancer Patients: The KASID Multicenter Study.
Oncology - 1 Jan 2023
Kim Tae-Woo, Hwang Soon Woo, Kim Kyeong Ok, Cha Jae Myung, Joo Young-Eun, Cho Young-Seok
Abstract excerpt
INTRODUCTION: KRAS, BRAF, and DNA mismatch repair (MMR) mutations aid clinical decision-making for colorectal cancer (CRC) patients. To ensure accurate predictions, the prognostic utilities of these biomarkers and their combinations must be individualized for patients with various TNM stages. METHODS: Here, we retrospectively analyzed the clinicopathological features of 904 Korean CRC patients who underwent CRC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
